Day: June 25, 2025
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) — Nevada Zinc Corporation (“Nevada Zinc” or the “Company”) (TSX-V: NZN) is pleased to announce that, further to the its news release dated July 24, 2024, the Company has completed the sale of its interest (the “Transaction”) in its mineral claims located in Eureka County, Nevada (the “Property”) to Minaurum Gold Corp (“Minaurum”) pursuant to the sale and option agreement dated July 24, 2024 (the “Agreement”), as amended.
The Property is made up of 203 mineral claims located in Eureka County, Nevada which are comprised of:
(i) 1 patented claim (the “Patented Claim”) and 26 unpatented lode claims, all of which are 100% legally and beneficially owned by the Company’s wholly owned subsidiary, Lone Mountain Zinc Ltd. (collectively, the “Owned Claims”); and
(ii) 176 unpatented...
Eureka Acquisition Corp Announces Revised Contribution to Trust Account and Terms and Conditions in Connection with Proposed Charter Amendment
Written by Customer Service on . Posted in Public Companies.
New York, June 25, 2025 (GLOBE NEWSWIRE) — Eureka Acquisition Corp (the “Company”) (Nasdaq: EURK), a blank check company, today announced that in connection with its previously announced extraordinary general meeting in lieu of an annual general meeting of shareholders to be held on June 30, 2025, at 9:00 a.m., Eastern Time (the “Extraordinary General Meeting”), the Company has revised the contribution to its trust account and the terms and conditions in connection with the proposal to amend the Company’s current Charter (the “Charter Amendment Proposal”).
The Charter Amendment Proposal provides that the Company has until July 3, 2025 to complete a business combination, and may elect to extend the period to consummate a business combination up to 12 times, each by an additional one-month extension (the “Monthly Extension”), for...
Acceleware Announces RF XL 2.0
Written by Customer Service on . Posted in Public Companies.
CALGARY, Alberta, June 25, 2025 (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine regeneration (for carbon capture and other applications), and enhanced oil production, is pleased to announce details of the next generation of RF XL, (“RF XL 2.0”) and a new demonstration plan (the “Demonstration”).
“RF XL”, Acceleware’s enhanced oil recovery (“EOR”) technology that uses RF heating to energize oil formations, is a major innovation that could potentially decarbonize heavy oil and oil sands production effectively and efficiently by materially lowering costs compared to other EOR techniques, increasing the recovery factor, and potentially stimulating investment.
The...
Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26
Written by Customer Service on . Posted in Public Companies.
Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T.
GAITHERSBURG, Md., June 25, 2025 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, will host an investor webcast on Thursday, June 26, 2025 at 8:30 am E.T. to present topline 24 week data from its IMPACT Phase 2b trial evaluating pemvidutide in the treatment of patients with metabolic dysfunction-associated steatohepatitis (MASH).
Conference Call InformationThe Company will host a conference call and webcast at 8:30 am E.T. on June 26, 2025. The call will include remarks from Altimmune management and Dr. Mazen Noureddin, Professor of Medicine at the Houston Methodist Hospital and Co-Chairman of the Board for Summit Clinical...
Rakovina Therapeutics Announces Results from 2025 Annual General Meeting
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery is pleased to announce the results of voting at its 2025 annual general meeting of shareholders held on June 25, 2025, in Vancouver, British Columbia (the “Meeting”).
All five members of the Company’s board of directors named as nominees in its management information circular dated May 26, 2025 (the “Circular”) were elected as directors: Jeffrey Bacha, Dr. Dennis Brown, Alfredo De Lucrezia, Yevgeniy Meshcherekov and Dr. David Kideckel.
In addition, at the Meeting, the shareholders of the Company: (i) approved the re-appointment of Davidson & Company LLP...
Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing
Five U.S. government proposals submitted, totalling up to US$125 million
HALIFAX, Nova Scotia, June 25, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and operational results for the fiscal year ended March 31, 2025 (“FYE 2025”), and provided an update on fiscal 2026. All figures are stated in Canadian dollars unless otherwise stated.
“The recent commercial re-launch of LIKMEZ® (ATI-1501), following new patent coverage through to 2039, marked a major milestone for Appili and our partner, Saptalis Pharmaceuticals, LLC (“Saptalis”)....
Hapbee Announces CDN$1.5M Private Placement Led by Company Executive; Announces Appointment of Ahsan Ashraf as Chief Technology Officer
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) — Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company, is pleased to announce a non-brokered private placement consisting of up to 15,070,000 units (“Units”) at a price of $0.10 per Unit for aggregate gross proceeds of up to $1,507,000 (the “Offering”). Each Unit will consist of one subordinate voting common share of the Company (a “Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will be exercisable for one additional Share of the Company at a price of $0.20 CAD for two years from the date of issuance.
Building upon the company’s significant growth over the past two fiscal quarters, the proceeds from the Offering will be strategically...
Clairvest Reports Fiscal 2025 Fourth Quarter and Year End Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) — Clairvest Group Inc. (TSX: CVG) today reported results for the fourth quarter and year ended March 31, 2025 and events which occurred subsequent to year end. (All figures are in Canadian dollars unless otherwise stated)
HighlightsMarch 31, 2025 book value was $1,251.6 million or $88.30 per share compared with $1,234.3 million or $86.78 per share as at December 31, 2024 and $1,176.3 million or $80.16 per share as at March 31, 2024
Net income for the fourth quarter was $20.7 million or $1.46 per share as the fair value of certain investments increased
Net income for fiscal 2025 was $122.0 million or $8.47 per share. During fiscal 2025, Clairvest had $46.1 million of net realized gains from the realization of four investments and $44.8 million of net investment gains on its remaining private...
CVB Financial Corp. Announces 143rd Consecutive Quarterly Cash Dividend
Written by Customer Service on . Posted in Dividend Reports And Estimates.
Ontario, CA, June 25, 2025 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the second quarter of 2025. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on June 25, 2025. The quarterly dividend will be payable on or about July 24, 2025 to shareholders of record as of July 10, 2025.
“We are pleased to announce our 143rd consecutive quarterly cash dividend paid to our shareholders,” said David A. Brager, President and Chief Executive Officer.
Corporate OverviewCVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank. CVBF is one of the 10 largest bank holding companies headquartered in California with greater than $15 billion in total assets. Citizens Business Bank is consistently...
ROHM Launches an Isolated Gate Driver IC Optimized for High-Voltage GaN Devices
Written by Customer Service on . Posted in Public Companies.
Isolated Gate Driver ICOptimized for driving 600V-class high-voltage GaN HEMTsSanta Clara, CA and Kyoto, Japan, June 25, 2025 (GLOBE NEWSWIRE) — ROHM Semiconductor today announced the development of the BM6GD11BFJ-LB, an isolated gate driver IC optimized for driving 600V-class high-voltage GaN HEMTs. When combined with GaN devices, this driver enables stable operation under high-frequency, high-speed switching conditions – contributing to greater miniaturization and efficiency in high-current applications such as motors and server power supplies.
As global energy consumption continues to grow, energy-saving initiatives have become a shared global priority. Motors and power supplies alone are estimated to account for approx. 97% of the world’s total electricity consumption. Achieving higher efficiency in these systems...